Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice

Naoki Makino, Toyoki Maeda, Jun ichi Oyama, Makoto Sasaki, Yoshihiro Higuchi, Koji Mimori, Takahiko Shimizu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Oxidative stress plays a pathological role in the development of heart failure. This study examined telomere biology in heart/muscle-specific manganese superoxide dismutase-deficient mice (H/M-SOD2-/-), which develop progressive congestive heart failure and exhibit pathology typical of dilated cardiomyopathy. EUK-8 (25mg/kg/day), a superoxide dismutase and catalase mimetic, was administered to H/M-SOD2-/- mice for four weeks beginning at 8weeks of age. Telomere length, telomerase activity, telomere-associated proteins, and cell death signals were assessed in hearts from control wild-type mice (H/M-Sod2 lox/ lox) and H/M-SOD2-/- mice either treated or untreated with EUK-8. While cardiac function was unchanged in these experimental mice, the end-diastolic dimension in H/M-SOD2-/- mice was notably dilated and could be significantly reduced by EUK-8 treatment. At the end of the study, no shortening of telomere length was observed in heart tissues from all mice tested, but telomerase activity was decreased in heart tissue from H/M-SOD2-/- mice compared to control mice. Protein expression for telomerase reverse transcriptase and telomere repeat binding factor 2 was also downregulated in H/M-SOD2-/- heart tissue as was expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase. Expression levels of Sirt1, a lifespan modulator, were enhanced while FoxO3a was depressed in H/M-SOD2-/- hearts. All of the changes seen in H/M-SOD2-/- heart tissue could be inhibited by EUK-8 treatment. Taken together, the results suggest that oxidant stress might affect myocardial telomerase activity and telomere-associated proteins. Telomerase may therefore play a pivotal role in antioxidant defense mechanisms, and may be useful as a novel therapeutic tool for treating human heart failure.

Original languageEnglish
Pages (from-to)670-677
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume50
Issue number4
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

Telomerase
Superoxide Dismutase
Antioxidants
Telomere
Therapeutics
Heart Failure
Telomere-Binding Proteins
Telomere Shortening
Proteins
Nitric Oxide Synthase Type III
Dilated Cardiomyopathy
Somatomedins
Oxidants
Catalase
Myocardium
Oxidative Stress
Cell Death
Down-Regulation
Pathology
N,N'-bis(salicylideneamino)ethane-manganese(II)

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice. / Makino, Naoki; Maeda, Toyoki; Oyama, Jun ichi; Sasaki, Makoto; Higuchi, Yoshihiro; Mimori, Koji; Shimizu, Takahiko.

In: Journal of Molecular and Cellular Cardiology, Vol. 50, No. 4, 01.04.2011, p. 670-677.

Research output: Contribution to journalArticle

@article{d6bb1603170b465f916e3a39b3c82f2c,
title = "Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice",
abstract = "Oxidative stress plays a pathological role in the development of heart failure. This study examined telomere biology in heart/muscle-specific manganese superoxide dismutase-deficient mice (H/M-SOD2-/-), which develop progressive congestive heart failure and exhibit pathology typical of dilated cardiomyopathy. EUK-8 (25mg/kg/day), a superoxide dismutase and catalase mimetic, was administered to H/M-SOD2-/- mice for four weeks beginning at 8weeks of age. Telomere length, telomerase activity, telomere-associated proteins, and cell death signals were assessed in hearts from control wild-type mice (H/M-Sod2 lox/ lox) and H/M-SOD2-/- mice either treated or untreated with EUK-8. While cardiac function was unchanged in these experimental mice, the end-diastolic dimension in H/M-SOD2-/- mice was notably dilated and could be significantly reduced by EUK-8 treatment. At the end of the study, no shortening of telomere length was observed in heart tissues from all mice tested, but telomerase activity was decreased in heart tissue from H/M-SOD2-/- mice compared to control mice. Protein expression for telomerase reverse transcriptase and telomere repeat binding factor 2 was also downregulated in H/M-SOD2-/- heart tissue as was expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase. Expression levels of Sirt1, a lifespan modulator, were enhanced while FoxO3a was depressed in H/M-SOD2-/- hearts. All of the changes seen in H/M-SOD2-/- heart tissue could be inhibited by EUK-8 treatment. Taken together, the results suggest that oxidant stress might affect myocardial telomerase activity and telomere-associated proteins. Telomerase may therefore play a pivotal role in antioxidant defense mechanisms, and may be useful as a novel therapeutic tool for treating human heart failure.",
author = "Naoki Makino and Toyoki Maeda and Oyama, {Jun ichi} and Makoto Sasaki and Yoshihiro Higuchi and Koji Mimori and Takahiko Shimizu",
year = "2011",
month = "4",
day = "1",
doi = "10.1016/j.yjmcc.2010.12.014",
language = "English",
volume = "50",
pages = "670--677",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice

AU - Makino, Naoki

AU - Maeda, Toyoki

AU - Oyama, Jun ichi

AU - Sasaki, Makoto

AU - Higuchi, Yoshihiro

AU - Mimori, Koji

AU - Shimizu, Takahiko

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Oxidative stress plays a pathological role in the development of heart failure. This study examined telomere biology in heart/muscle-specific manganese superoxide dismutase-deficient mice (H/M-SOD2-/-), which develop progressive congestive heart failure and exhibit pathology typical of dilated cardiomyopathy. EUK-8 (25mg/kg/day), a superoxide dismutase and catalase mimetic, was administered to H/M-SOD2-/- mice for four weeks beginning at 8weeks of age. Telomere length, telomerase activity, telomere-associated proteins, and cell death signals were assessed in hearts from control wild-type mice (H/M-Sod2 lox/ lox) and H/M-SOD2-/- mice either treated or untreated with EUK-8. While cardiac function was unchanged in these experimental mice, the end-diastolic dimension in H/M-SOD2-/- mice was notably dilated and could be significantly reduced by EUK-8 treatment. At the end of the study, no shortening of telomere length was observed in heart tissues from all mice tested, but telomerase activity was decreased in heart tissue from H/M-SOD2-/- mice compared to control mice. Protein expression for telomerase reverse transcriptase and telomere repeat binding factor 2 was also downregulated in H/M-SOD2-/- heart tissue as was expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase. Expression levels of Sirt1, a lifespan modulator, were enhanced while FoxO3a was depressed in H/M-SOD2-/- hearts. All of the changes seen in H/M-SOD2-/- heart tissue could be inhibited by EUK-8 treatment. Taken together, the results suggest that oxidant stress might affect myocardial telomerase activity and telomere-associated proteins. Telomerase may therefore play a pivotal role in antioxidant defense mechanisms, and may be useful as a novel therapeutic tool for treating human heart failure.

AB - Oxidative stress plays a pathological role in the development of heart failure. This study examined telomere biology in heart/muscle-specific manganese superoxide dismutase-deficient mice (H/M-SOD2-/-), which develop progressive congestive heart failure and exhibit pathology typical of dilated cardiomyopathy. EUK-8 (25mg/kg/day), a superoxide dismutase and catalase mimetic, was administered to H/M-SOD2-/- mice for four weeks beginning at 8weeks of age. Telomere length, telomerase activity, telomere-associated proteins, and cell death signals were assessed in hearts from control wild-type mice (H/M-Sod2 lox/ lox) and H/M-SOD2-/- mice either treated or untreated with EUK-8. While cardiac function was unchanged in these experimental mice, the end-diastolic dimension in H/M-SOD2-/- mice was notably dilated and could be significantly reduced by EUK-8 treatment. At the end of the study, no shortening of telomere length was observed in heart tissues from all mice tested, but telomerase activity was decreased in heart tissue from H/M-SOD2-/- mice compared to control mice. Protein expression for telomerase reverse transcriptase and telomere repeat binding factor 2 was also downregulated in H/M-SOD2-/- heart tissue as was expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase. Expression levels of Sirt1, a lifespan modulator, were enhanced while FoxO3a was depressed in H/M-SOD2-/- hearts. All of the changes seen in H/M-SOD2-/- heart tissue could be inhibited by EUK-8 treatment. Taken together, the results suggest that oxidant stress might affect myocardial telomerase activity and telomere-associated proteins. Telomerase may therefore play a pivotal role in antioxidant defense mechanisms, and may be useful as a novel therapeutic tool for treating human heart failure.

UR - http://www.scopus.com/inward/record.url?scp=79952071587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952071587&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2010.12.014

DO - 10.1016/j.yjmcc.2010.12.014

M3 - Article

C2 - 21195081

AN - SCOPUS:79952071587

VL - 50

SP - 670

EP - 677

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 4

ER -